Rezultati pretraživanja
  1. prije 9 sati

    ⬇ Sell (-44%) for ⬇ Sell (-22%) for ⬆⬆ Strong Buy (78%) for ⬆⬆ Strong Buy (78%) for ⬇ Sell (0%) for

    1 korisnik označava da mu se sviđa
  2. prije 9 sati

    is High of Day $2.63 - Huge acquisitions announced- Colorado Marijuana - Chart>

    2 korisnika označavaju da im se sviđa
  3. prije 14 sati

    short squeeze on Filings coming.. Get your tickets. The DD is not shabby either. Company being run by 2 Nasdaq execs.

    2 korisnika označavaju da im se sviđa
  4. prije 15 sati

    . Listed Small & Penny Stock Ideas Our 15th Year!

    1 korisnik označava da mu se sviđa
  5. prije 15 sati

    Call/Put Highest % Volume Changes: Calls: , , , , Puts: , , , ,

    1 proslijeđeni tweet
  6. prije 18 sati

    251 Profit-Packed Option Trades Yearly--Delivered to Your Inbox Daily--FREE!

    1 korisnik označava da mu se sviđa
  7. 3. velj

    Big News - Major Stakeholder -- Stuart Yarbrough - No longer Director of Cision LTD - Cision gets Acquired. -- He helps funds companies! Full attention towards MILV 🤑

    1 reply 7 proslijeđenih tweetova 9 korisnika označava da im se sviđa
  8. 29. sij

    DOWN 64% BOUNCING AFTERHOURS! OVERPANIC💸📈 $CVS 

  9. 28. sij

    I will get the news out! booming!! ... Lots of eyes on it now!!

  10. 27. sij

    A Beginner’s Guide to Stock Investing. On Amazon. Link:

  11. 21. sij

    7 expected blockbuster drug launches in 2020: - Trastuzumab deruxtecan - Palforzia - Ozanimod - Inclisiran - Roxadustat - Sacituzumab Govitecan - Filgotinib

    21 proslijeđeni tweet 55 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  12. 16. sij

    Besides the valuation gap between buyers and sellers, think the other big factor is that we had 3 mega-mergers that effectively took 6 of the most prolific dealmakers off the buyers' list for now ->

    This is probably the most interesting stat in 2020 E&Y Firepower Report and explains the lack of M&A at "69% of surveyed dealmakers say the valuation gap between buyers and sellers is the largest its been since 2008"
    8 proslijeđenih tweetova 49 korisnika označava da im se sviđa
  13. 12. sij

    JPM Healthcare kicks off on Monday. Last year bought ... I'll be watching news in this sector like a hawk next 4 days. Chart has cooled off very nicely now, ready for next leg up...

    3 proslijeđena tweeta 19 korisnika označava da im se sviđa
  14. 10. sij

    On this same morning last year - by which I mean the Thursday before JPM - we woke up to the news that was acquiring , just days before we () were to sign a major agreement with .

    1 reply 3 proslijeđena tweeta 18 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  15. 9. sij

    bought last year. At this time -Stock tanked - now year later setting at all time highs 65.70. -big takeovers can work - needs to do about 3-4 deals to totaling about 50-60 billion to really move needle -good news is they have more fire power then had

    4 proslijeđena tweeta 23 korisnika označavaju da im se sviđa
  16. 9. sij

    CMO says co. confident on track to receive US approvals for drugs tied to CVR -interview.

    2 proslijeđena tweeta 11 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  17. 9. sij

    Key players focused on reduced intensity conditioning Anti-CD47: Novimmune, Arch & ALX Anti-CD45: Anti-CD117: & Jasper Partners: Notably, is a 10x mover in the last month.

    19 proslijeđenih tweetova 54 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  18. 18. pro 2019.

    Bristol-Myers Squibb Announces Submission of Biologics License Application for CAR T-Cell Therapy Lisocabtagene Maraleucel (liso-cel) to FDA

    7 proslijeđenih tweetova 7 korisnika označava da im se sviđa
  19. 16. pro 2019.

    gets the Monday morning kickoff slot formerly owned by

    Here's the preliminary schedule.
    5 proslijeđenih tweetova 25 korisnika označava da im se sviđa
  20. 8. pro 2019.

    If you're invested in the CVR read my take on yesterday's Transcend-NHL data at . Via

    1 reply 11 proslijeđenih tweetova 35 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.